ClearPoint Neuro: Gene Therapy Partner and new Robotic Technology Cause a Share Price Explosion

With its MRI-based navigation systems, ClearPoint occupies a nearly unmatched niche for minimally invasive brain surgery. The company is considered a major beneficiary in the field of gene therapies. However, the high expectations associated with it have not been fully met in recent years. Since September 24, 2025, positive news has been rolling in. The stock is now at its highest level since February 2021. An additional increase of 15% would even mean the highest point since July 2015. The convincing study results for combating Huntington's...